|
contents | europe | ||||
| Independent Studies on FzioMed's Anti-Adhesion Gel FzioMed, Inc. announced reports of positive clinical experiences by European surgeons using the company's adhesion barrier gel to prevent postoperative adhesions from forming after back surgery. Presentations are being made at annual meetings of the Congress of Neurological Surgeons (CNS) in Chicago and at the upcoming European Spine Society's Annual Meeting (EuroSpine) to be held October 25-28 in Istanbul, Turkey. FzioMed's adhesion barrier is an injectable, absorbable gel, in a 3mL syringe, for use in reducing the incidence, extent and severity of postsurgical adhesions following lumbar spine surgery. Postsurgical adhesions are abnormal bands of scar tissue that can form between tissues following surgery and cause postoperative complications such as recurrent back pain and weakness. The gel is placed in the epidural space during laminectomy, laminotomy, and discectomy procedures to separate tissues and act as a temporary, protective barrier against adhesion formation. The product is marketed outside the United States as MediShield Anti-Adhesion Gel and as Oxiplex /SP Adhesion Barrier Gel. FzioMed is completing a pivotal clinical trial of Oxiplex/SP in the U.S. write your comments about the article :: © 2006 Exhibition News :: home page |